HPV and Throat Cancer in 2026 — The Silent ENT Epidemic Affecting Young Adults

sanjeev mohanty
3 hours ago
6 min read

By Dr. Sanjeev Mohanty | ENT, Head & Neck Surgeon | Dr. Mohanty's Speciality ENT Clinics, Chennai

If I told you that one of the fastest-growing cancers in the world right now is a throat cancer — and that it predominantly affects people who have never smoked a cigarette in their lives — you would probably be surprised. Most people are.

HPV-related oropharyngeal cancer is the ENT story of our generation. And in 2026, it is reaching epidemic proportions globally.

As a head and neck surgeon who has cared for patients with throat cancer for over 25 years, I feel a genuine urgency to put this information in front of as many people as possible. Because unlike many cancers, this one is preventable. And when caught early, it is highly treatable.

What Exactly is HPV?

HPV stands for Human Papillomavirus. It is the most common sexually transmitted infection in the world. The WHO estimates that virtually all sexually active people will be infected with at least one strain of HPV during their lifetime.

Most HPV infections clear on their own without causing any symptoms or problems. The immune system handles them quietly. But certain high-risk strains — particularly HPV-16 and HPV-18 — can linger in the body, sometimes for decades, before triggering abnormal cell growth that becomes cancer.

For years, HPV was discussed almost exclusively in the context of cervical cancer. But the picture has now dramatically changed.

HPV Has Now Overtaken Cervical Cancer as the #1 HPV-Related Cancer in High-Income Countries

Research published in PubMed's cancer epidemiology databases confirms a startling shift: in the United States and other developed nations, oropharyngeal cancer (throat cancer caused by HPV) has now overtaken cervical cancer as the most common HPV-related malignancy. In India and Southeast Asia, the same trend is beginning to emerge.

A 2026 report from the American Association for Cancer Research described oropharyngeal cancer as 'epidemic' — a word that medical professionals do not use lightly. The rate of growth is that significant.

Who Is Getting This Cancer — And Why?

This is where the story gets particularly important. HPV-related throat cancer does not follow the traditional head and neck cancer profile of heavy smokers and heavy drinkers in their 70s.

The typical HPV-positive throat cancer patient in 2026 is:

• A non-smoker or light smoker

• Between the ages of 40 and 65 (though increasingly seen in younger adults)

• Often appears very healthy overall

• Frequently male (men are four to five times more likely to develop HPV-related throat cancer)

• Has had multiple sexual partners or oral sexual contact over their lifetime

The link between oral sexual practices and throat HPV transmission is well-established in the scientific literature. Research from Johns Hopkins University found that having six or more oral sex partners increases the risk of HPV-related throat cancer fivefold.

I raise this not to shock or to stigmatise, but because understanding the route of transmission is essential for prevention. This is a public health issue that requires open, honest conversation.

The Warning Signs — What to Look For

One of the greatest challenges with HPV-related throat cancer is that it is often called the 'silent cancer'. In early stages, it may produce no symptoms at all. When symptoms do appear, they include:

• A painless lump or swelling in the neck (most common first sign)

• Persistent sore throat that does not resolve with antibiotics

• Difficulty swallowing or a sensation of something stuck in the throat

• Unexplained ear pain on one side

• Hoarseness or change in voice that persists

• Unexplained weight loss

"The most common presentation I see is a patient — usually a man in his 50s — who notices a lump in the neck while shaving. He may have had it for months, dismissed it as a lymph node. Often it's the first sign of oropharyngeal cancer. Time matters enormously." — Dr. Sanjeev Mohanty, ENT Surgeon

The Survival Story — Why HPV-Positive Cancer Is Different

Here is genuinely good news: HPV-positive throat cancers have significantly better outcomes than HPV-negative cancers. A 2026 analysis of cancer survival data found that HPV-positive oropharyngeal cancers have a 5-year survival rate of 82–95%, compared to 57–62% for HPV-negative cancers of the same area.

Why the difference? HPV-related tumours tend to respond exceptionally well to radiation therapy and chemotherapy. This is partly because the patients tend to be younger, healthier overall, and have fewer comorbid conditions — but also because of specific biological properties of HPV-related tumours.

The catch, of course, is that these excellent survival rates are predicated on catching the cancer early. Late-stage diagnosis dramatically changes the outlook.

Prevention — The HPV Vaccine Is the Answer

The HPV vaccine is one of the most remarkable cancer prevention tools in the history of modern medicine. Preliminary findings from a major U.S. study found that men who received the HPV vaccine had a 56% reduction in rates of head and neck cancers. A global study reported a five-fold reduction in oral cavity and pharynx cancers.

The vaccine works best when given before any HPV exposure — ideally to adolescents between the ages of 9 and 12. In many countries, it is now recommended for both boys and girls. Adults up to age 45 may still benefit, particularly if they have had limited prior HPV exposure.

In May 2026, South Korea began offering free HPV vaccination to 12-year-old boys as part of their national health programme — a direct response to the rising rates of HPV-related throat cancer. India is watching closely.

What About Adults Who Weren't Vaccinated?

If you were not vaccinated as a child, the conversation is more nuanced. Discuss with your doctor whether vaccination is still beneficial for you. But regardless of vaccination status, there are things you can do:

• Be aware of the warning signs and act quickly if any appear

• Inform your dentist — oral cavity and tonsil examinations during dental check-ups can pick up early lesions

• Reduce other risk factors: stop smoking, moderate alcohol consumption

• If you are a parent, ensure your children are vaccinated at the recommended age

HPV and Throat Cancer in the Indian Context

India has the second-largest population in the world, and a significant proportion of head and neck cancers in this country are still primarily tobacco-related. Oral cancers (from chewing tobacco and betel nut) remain the dominant concern.

However, as tobacco use patterns change and Western lifestyle influences spread, HPV-related throat cancers are beginning to rise in urban India. Awareness is critically low. Most patients I see who are eventually diagnosed with HPV-related throat cancer had never even heard of the connection between HPV and throat cancer before their diagnosis.

That needs to change. And education is where it starts.

What We Do at Dr. Mohanty's Clinics

As a head and neck surgeon, managing cancers of the throat, larynx, and neck is one of my primary clinical responsibilities. When a patient presents with a neck lump, persistent throat symptoms, or any of the warning signs I've described, our approach is systematic and thorough:

• Detailed clinical examination including flexible nasendoscopy

• Imaging with ultrasound, CT, and MRI as indicated

• Fine needle aspiration cytology (FNAC) for neck lumps

• Biopsy under anaesthesia when required

• HPV testing of tumour tissue to guide treatment planning

• Multidisciplinary team coordination with oncology and radiation therapy

Every patient is treated as an individual — not a case number. The journey through a cancer diagnosis is frightening. My commitment to every patient is to be a knowledgeable, compassionate guide through that journey.

Conclusion — Don't Be a Silent Statistic

HPV-related throat cancer is rising worldwide. It affects people who did everything 'right' — they never smoked, they weren't heavy drinkers. They are shocked when they receive the diagnosis.

The tools to fight this cancer exist. The vaccine can prevent new cases. Early detection dramatically improves survival. And treatment of HPV-positive throat cancer, when caught early, can achieve outcomes that would have seemed extraordinary just a generation ago.

Please — if you have a persistent neck lump, a sore throat that won't go away, or any of the symptoms I've described — do not wait. Come in. Let us check. Five minutes of examination could make all the difference.

📞 Urgent Appointments: +91 97910 74677

🌐 www.drsanjeevmohanty.com

#ThroatCancer #HPVCancer #HeadAndNeckCancer #HPVVaccine #ENTChennai #DrSanjeevMohanty #CancerAwareness